Optovue Avanti / AngioVue
Modality: Ophthalmic OCT
Optovue's spectral-domain OCT + OCT-Angiography platform that established commercial clinical OCT-A in 2014–2015. Among the earliest commercial OCT-A systems at clinical scale; the platform whose clinical-evidence base shaped early OCT-A practice patterns. Predecessor to current-generation Solix; large legacy installed base in retinal practices that adopted OCT-A early.
Distinctive technology
- Early commercial OCT-Angiography — Avanti / AngioVue defined the clinical OCT-A category in 2014–2015.
- SSADA (Split-Spectrum Amplitude-Decorrelation Angiography) — Optovue's reconstruction technique.
- Wide-Field OCT-A — extended-FOV scans (15×9 mm class).
- AngioAnalytics — vessel-density and flow-area quantification.
Refurb posture
- Active refurb supply — Avanti turnover in retinal-practice upgrades to Solix.
- Software / OCT-A license version drives capability.
- Visionix-era service continuity post-2021 acquisition is a consideration.